Diabetes Technology and Therapeutics Impact Factor, Indexing, Ranking

Diabetes Technology and Therapeutics Impact Factor, Indexing, Ranking

Diabetes Technology and Therapeutics (DTr) is a scholarly journal dedicated to publishing research in the field of Medicine. Mary Ann Liebert is the publisher of this esteemed journal. The P-ISSN assigned to Diabetes Technology and Therapeutics is 1520-9156 and its abbreviated form is Dialogues Hum Geogr.


Aim and Scope

Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and each issue highlights new pharmacological and device developments to optimize patient care.

Diabetes Technology & Therapeutics coverage includes:

  • Detection and prevention of long-term micro- and macrovascular complications
  • Breakthrough technologies and new therapeutic drug classes
  • Behavioral aspects and approaches to diabetes care
  • The latest advancement and applications of new and emerging technologies, including:
    • Alternate insulin delivery methods
    • Continuous glucose monitoring
    • Artificial pancreas
    • Computerized case management/telemedicine
    • New insulins with ultra-rapid onset of action
    • Detection and prevention of hypoglycemia

Journal Details

Journal title Diabetes Technology and Therapeutics (DTr)
Abbreviation Dialogues Hum Geogr
Print ISSN 1520-9156
Online ISSN 1557-8593
Publisher Name Mary Ann Liebert
Editor-in-chief Satish K. Garg
Subject Category Medicine

Abbreviation

Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Diabetes Technology and Therapeutics Journal is Dialogues Hum Geogr.


Ranking

The Ranking of the Journal in 2024 is 986. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.


Impact Factor

The Journal's Impact Factor in 2024 is 5.4. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.

List of All Journal Impact Factors


SCImago

The Journal SCImago in 2024 is 2.374. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.


H-Index

The Journal's H-Index in 2024 is 97. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.


Quartile

The Journal's Quartile is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.


Journal's Indexing

The Journal is indexed in (Indexing details)

PubMed Scopus Web of Science UGC Embase DOAJ

Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.


Journal's Metrics for 2024

Abbreviation Dialogues Hum Geogr
Access type Hybrid
Impact Factor 5.4
SJR 2.374
SNIP 1.908
Ranking 986
CiteScore 11.6
H-Index 97

Editorial Board

The Editor-in-chief of the Journal is Satish K. Garg


Submission/Processing Fee (APC)

Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.

The APC/Submission (Publication) Fee of the Journal is $3,600 USD


Call for paper

Call for paper : The Journal invites original research contributions for consideration of publication in Diabetes Technology and Therapeutics journal.

Journal seeking submissions in the broad areas of Medicine that align with journal's focus on Medicine.

for details about call for paper please visit to the official website of the journal to check the details about call for papers.


How to publish in Diabetes Technology and Therapeutics

Publishing in Diabetes Technology and Therapeutics involves the following steps:

  • Research: Conduct high-quality, impactful research in the field of Medicine.
  • Familiarize Yourself: Read and understand the aims and scope of Diabetes Technology and Therapeutics to ensure your work aligns with their focus.
  • Manuscript Preparation: Prepare your manuscript according to the Diabetes Technology and Therapeutics guidelines, including formatting, length, and referencing style.
  • Submission: Submit your manuscript through the journal's online submission system.

Diabetes Technology and Therapeutics FAQ

is journal indexed in PubMed?

No, the journal is not indexed in PubMed.

is journal indexed in Scopus?

Yes, the journal is indexed in Scopus.

is journal indexed in UGC?

Yes, the journal is indexed in UGC.

is journal indexed in Index Copernicus?

No, the journal is not indexed in Index copernicus.

is a predatory journal?

No, journal is not a predatory journal.

What is the Imptact Factor of Diabetes Technology and Therapeutics?

The Impact Factor of the Journal is 5.4.

What is the Ranking of the Journal?

The Ranking of the Journal is 986.

is journal peer reviewed?

Yes the journal is a peer-reviewed journal.

is Diabetes Technology and Therapeutics a good journal?

Yes the journal is a peer-reviewed journal and good to publish your paper.

What is Diabetes Technology and Therapeutics?

Diabetes Technology and Therapeutics (DTr) is a scholarly journal dedicated to publishing research in the field of Medicine. Mary Ann Liebert is the publisher of this esteemed journal.

is Diabetes Technology and Therapeutics open access?

Yes, Diabetes Technology and Therapeutics is a open access (Hybrid) journal.


Table of Contents

Search For Journals, Indexing, Impact Factor etc.